Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heartflow (HTFL) Gains from Sales and Divestitures (2025)

Heartflow has reported Gains from Sales and Divestitures over the past 1 years, most recently at $47018.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $47018.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $47018.0 (changed N/A YoY), and the annual figure for FY2025 was $47018.0, changed.
  • Gains from Sales and Divestitures for Q4 2025 was $47018.0 at Heartflow.
  • Over the last five years, Gains from Sales and Divestitures for HTFL hit a ceiling of $47018.0 in Q4 2025 and a floor of $47018.0 in Q4 2025.